Free Trial
NASDAQ:RNTX

Rein Therapeutics (RNTX) Stock Price, News & Analysis

Rein Therapeutics logo
$1.42 -0.13 (-8.39%)
As of 03:34 PM Eastern

About Rein Therapeutics Stock (NASDAQ:RNTX)

Key Stats

Today's Range
$1.42
$1.58
50-Day Range
$1.38
$2.21
52-Week Range
$1.33
$4.40
Volume
33,716 shs
Average Volume
39,555 shs
Market Capitalization
$31.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rein Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RNTX Stock News Headlines

RNTX - Rein Therapeutics Inc Dividends - Morningstar
Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.
RNTX Rein Therapeutics Inc.
See More Headlines

RNTX Stock Analysis - Frequently Asked Questions

Rein Therapeutics' stock was trading at $2.05 at the beginning of the year. Since then, RNTX shares have decreased by 30.7% and is now trading at $1.42.

Rein Therapeutics Inc. (NASDAQ:RNTX) released its quarterly earnings data on Thursday, May, 15th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.04.

Top institutional shareholders of Rein Therapeutics include Blair William & Co. IL (0.11%).

Shares of RNTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RNTX
CIK
1420565
Web
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$62.88 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-86.07%
Return on Assets
-31.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.39
Quick Ratio
1.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.48 per share
Price / Cash Flow
3.08
Book Value
$0.43 per share
Price / Book
3.44

Miscellaneous

Outstanding Shares
22,150,000
Free Float
21,024,000
Market Cap
$32.78 million
Optionable
N/A
Beta
1.22
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:RNTX) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners